Drug Type Antibody |
Synonyms- |
Target |
Action antagonists |
Mechanism GPCR antagonists(G-protein coupled receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | United Kingdom | 12 May 2025 | |
| Autoimmune Diseases | Discovery | United Kingdom | 12 May 2025 |






